Pfizer and Moderna booster shots effective against Omicron, CDC data shows; British fund manager and shareholder Terry Smith criticizes failed Unilever bid for GSK consumer business; Democrats begin to revise Build Back Better plan in hopes of passing new version.
Five things for pharma marketers to know: Friday, January 21, 2022
Merck to make COVID-19 pill available for generic manufacturers; Unilever won’t increase offer for GSK’s consumer healthcare business; Top Merck exec to depart for International Flavors & Fragrances.
Five things for health marketers to know: Thursday, January 20, 2022
Biden administration to distribute 400 million free masks; CDC: Vaxxed people with prior infections most protected against Delta; Biotech veterans launch Altos Labs.
The Vaccine Project Newsletter: Finite disappointment, infinite hope
Biden administration to distribute 500 million free tests; Sensorion hearing loss drug fails in study; Advocacy groups push for CMS to cover Aduhelm for more people.
Inside the cruise industry’s aggressive pushback against the CDC